Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world cohort of older adults (≥ 65 years) with psoriasi...
Main Authors: | Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof, Elke M.G.J. de Jong, Satish F.K. Lubeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2022-10-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/2412 |
Similar Items
-
Age-based treatment differences in and reluctance to treating older adults with systemic antipsoriatic therapy – a mixed-method pilot study
by: Elke L. M. ter Haar, et al.
Published: (2022-10-01) -
Real‐life self‐assessment of pruritus relief with a combination of calcipotriol/betamethasone dipropionate foam in patients with plaque psoriasis
by: Laurent Misery, et al.
Published: (2022-12-01) -
Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
by: Andrea Cortese, et al.
Published: (2023-05-01) -
Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
by: Federico Diotallevi, et al.
Published: (2022-09-01) -
Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022-08-01)